Inovio Pharmaceuticals, Inc. (INO)

1.19 +0.03 (+2.59%) USD  |  NASDAQ  |  Apr 17, 16:00
1.20 +0.01 (+0.84%) Pre-Market: 20:00
More

Inovio Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for INO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Vaxart, Inc. Upgrade
Capricor Therapeutics, Inc. Upgrade
Allogene Therapeutics, Inc. --